GOAL
This activity is intended to provide health care professionals with an update regarding recommendations within the 2018 Cholesterol Guideline for the management of hypercholesterolemia, lipid-lowering medications, statin-associated side effects, and treatment of special populations.
LEARNING OBJECTIVES
Upon completion of this activity, the participant should be able to:
1. Describe the 2018 Cholesterol Guideline recommendations for patient-centered management of hypercholesterolemia
2. Compare and contrast currently available medications for the treatment of hypercholesterolemia
3. Identify the role in therapy for nonstatin medications
4. Explain statin cognitive side effects, new-onset diabetes, and muscle complaints
TARGET AUDIENCE
This accredited activity has been designed for pharmacists.
Postgraduate Healthcare Education, LLC ("PHE") provides Power-Pak C.E.® educational programs for the broad spectrum of healthcare professions. Professional medical and pharmaceutical education constitutes PHE's core activity. PHE continues to successfully produce continuing education programs for all professional healthcare disciplines including pharmacists, pharmacy technicians, physicians, nurses, physician assistants, and nurse practitioners.
